Beer&Co valuation of De Grey implies share price upside


Published 23-FEB-2017 15:51 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Shares in De Grey Mining (ASX:DEG) have increased nearly 50% since the start of 2017, but there has been plenty of strong news flow coming from the company, including a trebling of its Mt Berghaus gold resource and the strategic option to acquire the Indee gold project, an initiative that would significantly increase the group’s resources and reserves, provide access to essential infrastructure and lead to increased production.

On this basis, Pieter Bruinstroop from Beer&Co sees the budding Western Australian gold producer as substantially undervalued as can be seen from his modelling in the table below.

It should be noted here that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

Emerging 100,000 ounce plus producer with first gold in fiscal 2019

Based on Bruinstroop’s projections a combined Indee-Turner River project could hit maiden production in fiscal 2019 with production of 12,350 ounces. However, based on his modelling in the following year, production would jump to circa 140,000 ounces.

While this level of production wouldn’t be maintained in the ensuing two years, he sees the prospect of large-scale production in the vicinity of 170,000 ounces per annum occurring out from 2023-24.

The following table indicates Bruinstroop’s production estimates.

Some of the key takeaways noted by Bruinstroop were the fact that DEG now controls over 800,000 ounces from 16 million tonnes grading 1.5 grams per tonne in resources. With this acquisition he is of the view that DEG transitions from explorer to a gold project developer with granted mining licenses.

Substantial news flow to drive DEG share price

The broker expects a series of resource upgrades over the balance of 2017, along with results of a scoping study, followed by a feasibility study which it expects will be completed by the end of 2017.

The completion of these milestones are prospective share price catalysts, and as such DEG is shaping up as a news flow driven story in 2017 with the potential for its shares to push up towards Beer&Co’s valuation, particularly as the company is more readily recognised as an emerging producer rather than a production play.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free